BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25453566)

  • 21. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
    Jentschke M; Soergel P; Hillemanns P
    J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of HPV sign genotyping test with INNO-LiPA HPV genotyping extra assay on histologic and cytologic cervical specimens.
    Barbieri D; Nocera M; Gallinella G; Gentilomi GA; Plazzi M; Costa S; Santini D; Venturoli S
    Diagn Microbiol Infect Dis; 2012 Sep; 74(1):43-8. PubMed ID: 22717156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the PapilloCheck® assay with the digene HC2 HPV DNA assay for the detection of 13 high-risk human papillomaviruses in cervical and anal scrapes.
    Didelot MN; Boulle N; Damay A; Costes V; Segondy M
    J Med Virol; 2011 Aug; 83(8):1377-82. PubMed ID: 21678441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
    Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
    J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Classical molecular tests using urine samples as a potential screening tool for human papillomavirus detection in human immunodeficiency virus-infected women.
    Munoz M; Camargo M; Soto-De Leon SC; Sanchez R; Pineda-Peña AC; Perez-Prados A; Patarroyo ME; Patarroyo MA
    J Clin Microbiol; 2013 Nov; 51(11):3688-93. PubMed ID: 23985908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.
    Park Y; Lee E; Choi J; Jeong S; Kim HS
    J Clin Microbiol; 2012 Jul; 50(7):2359-65. PubMed ID: 22518863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set.
    Jones J; Powell NG; Tristram A; Fiander AN; Hibbitts S
    J Clin Virol; 2009 Jun; 45(2):100-4. PubMed ID: 19394266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and genotyping of HPV in urine samples from Chilean women attending primary health care centers.
    Vergara N; Balanda M; Hidalgo W; Martín HS; Aceituno A; Roldán F; Villalón T; Hott M; Espinoza G; Quiero A; Valenzuela MT; Ramírez E
    Med Microbiol Immunol; 2018 Apr; 207(2):95-103. PubMed ID: 29238853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot study to compare dry cervical sample collection with standard practice of wet cervical samples for human papillomavirus testing.
    Sultana F; Gertig DM; Wrede CD; English DR; Simpson JA; Drennan KT; Brotherton JM; Phillips G; Heley S; Castle PE; Saville M
    J Clin Virol; 2015 Aug; 69():210-3. PubMed ID: 26209409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes.
    Barzon L; Militello V; Pagni S; Palù G
    J Clin Virol; 2012 Nov; 55(3):256-61. PubMed ID: 22877561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-Risk Human Papillomavirus Detection in Urine Samples From a Referral Population With Cervical Biopsy-Proven High-Grade Lesions.
    Lorenzi AT; Fregnani JHT; Dockter J; Fitzgerald K; Strohecker E; Eaton B; Vibat CRT; Erlander MG; Scapulatempo-Neto C; Smith JS; Longatto-Filho A
    J Low Genit Tract Dis; 2018 Jan; 22(1):17-20. PubMed ID: 29271852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between Urine and Cervical Samples for HPV DNA Detection and Typing in Young Women in Colombia.
    Cómbita AL; Gheit T; González P; Puerto D; Murillo RH; Montoya L; Vorsters A; Van Keer S; Van Damme P; Tommasino M; Hernández-Suárez G; Sánchez L; Herrero R; Wiesner C
    Cancer Prev Res (Phila); 2016 Sep; 9(9):766-71. PubMed ID: 27417431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical samples dried on filter paper and dried vaginal tampons can be useful to investigate the circulation of high-risk HPV in Congo.
    Alidjinou EK; Ebatetou-Ataboho E; Sané F; Moukassa D; Dewilde A; Hober D
    J Clin Virol; 2013 Jun; 57(2):161-4. PubMed ID: 23478164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework.
    Ejegod DM; Hansen M; Christiansen IK; Pedersen H; Quint W; Xu L; Arbyn M; Bonde J
    J Clin Virol; 2020 Jul; 128():104336. PubMed ID: 32446166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples.
    Cornall AM; Poljak M; Garland SM; Phillips S; Machalek DA; Tan JH; Quinn MA; Tabrizi SN
    Papillomavirus Res; 2017 Dec; 4():79-84. PubMed ID: 29179874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens.
    Isidean SD; Coutlée F; Franco EL
    Expert Rev Mol Diagn; 2014 Jan; 14(1):5-16. PubMed ID: 24308341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
    Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
    J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.
    Cañadas MP; Cirigliano V; Darwich L; Sirera G; Coll J; Clotet B; Videla S
    J Virol Methods; 2012 Jul; 183(1):14-8. PubMed ID: 22449759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.